Careers • News • Contact us •
Exploring new avenues to develop tomorrow’s medical knowledge through an approach that integrates basic and clinical research
Our research units are led by principal investigators who collaborate in a spirit of collegiality and with the vision of bridging the gap between research and patients. They train the next generation of scientists and are independent and creative minds who work tirelessly to improve health.
One of the main objectives of this research unit is to study molecular mechanisms that control genetic regulation and expression in transgenic mice. Scientists on this team have produced a sickle cell transgenic mouse model through a mutation in the adult beta-globin gene to study the pathophysiology of the disease and to develop effective gene therapy approaches. They are also analyzing transcriptional factors involved in the most primitive cells of hematopoietic differentiation.
Furthermore, they are characterizing the PKD1 gene responsible for polycystic kidney disease and studying the signal transduction pathway using a transgenic mouse model induced with the protooncogène c-myc.
Team |
|
Affiliations |
|
Degrees and experience |
|
Press review |
DDO: plus de 150 personnes attendues à la marche pour soutenir les victimes de MPR - Journal Métro - 6 septembre 2016 |
Press review |
Grants |
Recognitions and honors |
514 987-5712
marie.trudel@ircm.qc.ca
© Montreal Clinical Research Institute, Année.All rights reserves. | Privacy policy | Terms of use | Web site by Agence Riposte